市場調查報告書

移植診斷的全球市場:成長、趨勢、預測(2020年∼2025年)

Transplant Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921926
出版日期 內容資訊 英文 111 Pages
商品交期: 2-3個工作天內
價格
移植診斷的全球市場:成長、趨勢、預測(2020年∼2025年) Transplant Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 111 Pages
簡介

移植診斷,在移植前,移植中,及移植後相關的各種方面的評估是必要。移植是對末期腎臟疾病患者和很多慢性透析患者來說有利的治療之一。末期腎臟疾病的盛行率高,在症狀進行的後期診斷出。移植診斷,對捐贈者和患者兩者進行。隨著技術進步,在已開發國家的綜合專門醫院施行的移植手術數量持續增加,另外,政府和民間團體的合作資金籌措的機會增加

本報告提供全球移植診斷市場調查,市場概要,各技術、產品、類型、用途、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 移植手術的發展
    • 移植診斷的技術性支援
    • 標的疾病的研究的政府和民間的合作
  • 市場阻礙因素
    • 移植成本高
    • 保險及償付制度
    • 器官移植相關的社會及道德問題
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第5章 市場區隔

  • 各技術
    • 分子
    • 非分子
  • 各產品
    • 設備
    • 試劑
    • 軟體
  • 各類型
    • 固態器官移植
    • 幹細胞移植
    • 軟組織移植
  • 各用途
    • 診斷
    • 研究
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • Biomerieux SA
    • Bio-Rad Laboratories Inc
    • CareDx
    • F. Hoffman-La Roche Limited
    • Hologic
    • Illumina
    • Qiagen
    • Thermo Fisher Scientific, Inc.

第7章 市場機會及未來趨勢

目錄
Product Code: 67617

Market Overview

Transplantation is among the preferred treatment option for many of the patients suffering from end-stage renal disease, and undergoing chronic dialysis therapy. There is a significant prevalence of patients suffering from end-stage renal disorders, for which the patients are being diagnosed at the later stage of the disease. In the past decade, the diagnostics have improved significantly with companies committed to developing better HLA typing technologies, antibody monitoring, instrument and software. Along with technological advancements, there are a growing number of transplant procedures being performed by the multispeciality hospitals in the developed markets and growing funding opportunities provided by the government and private collaborations. The diagnosis in transplants is done at both the donor and patients end to analyze the infection level inside the organ. However, some of the limitations include the high cost of transplants, insurance, and reimbursement policies, and social and ethical issues related to organ transplants.

Scope of the Report

The transplant diagnostics is necessary for the assessment of different aspects associated with a transplant during a pre-, peri-, and post-transplantation. The scope of the market report consists of segmentation by technology, product, transplant type, application, and geography.

Key Market Trends

Solid Organ Transplant Dominates the Market Segmentation by Transplant Type, Over the Forecast Period

Solid-organ transplantation, which started as an experimental approach in the 20th century is now considered as well-established and practical definitive treatment option for patients suffering from end-stage organ dysfunction. The major number of transplants done for kidney, followed by liver. Some of the technologies used during solid organ transplants include the emergence of molecular diagnostics. However, the greatest yield is obtained from PCR based techniques, which are widely accepted and used across the world. There is no gold standard for the transplant diagnostics, however, there are certain guidelines and tests recommended by the World Health Organization before and after the transplant procedures related to chronic advanced kidney diseases. The other transplants type is still in an experimental stage of development which is expected to grow at a healthy rate over the forecast period.

North America is Expected to Dominate the Market Among Other Regions, over the Forecast Period

Countries such as the United States and Canada are well-equipped with the funded organizations, infrastructure, as well as government participation in raising funds and awareness to promote transplantation of the diseased organs of the patients. There are several initiatives and awareness programs conducted by companies such as Roche collaborating with hospitals, organizations like the American Transplant Foundation to boost the organ donor rate. These companies are advanced in marketing new products for faster diagnostics of diseases before and after the transplants which are well accepted by the private organizations and government of the United States and Canada. Although there are more than 0.1 million awaiting transplants, mostly for kidney, there has been a steady rise in the number of liver donor rates followed by the deceased donor rate, which shows the improvement and demand of more diagnostics facilities across the healthcare facilities related to transplant. With a large section of the population across the world approach these two nations for better healthcare facilities, the region is expected to be very lucrative for growth and dominance over the forecast period.

Competitive Landscape

The technological advancement in terms of reagents effectiveness and affordability, clinicians decision making, as well as raising awareness and proper organ preservation facilities, are some of the present-day opportunities and challenges which the companies are expected to overcome, over the forecast period. Some of the major companies expanding in transplant diagnostics include Abbott Laboratories, Biomerieux SA, F Hoffmann La Roche, Qiagen, and ThermoFisher Scientific, among the rest.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Transplant Procedures
    • 4.2.2 Technological Advacements in Transplant Diagnostics
    • 4.2.3 Government and Private Collaboration into Funding Research of Target Diseases
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Transplant
    • 4.3.2 Insurance and Reimbursement Policies
    • 4.3.3 Social and Ethical Issues Related to Organ Transplant
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Technology
    • 5.1.1 Molecular
      • 5.1.1.1 PCR based Molecular Assays
      • 5.1.1.2 Sequencing Based Molecular Assays
    • 5.1.2 Non-Molecular
  • 5.2 By Product
    • 5.2.1 Instrument
    • 5.2.2 Reagent
    • 5.2.3 Software
  • 5.3 By Transplant Type
    • 5.3.1 Solid Organ Transplant
    • 5.3.2 Stem Cell Transplant
    • 5.3.3 Soft Tissue Transplant
  • 5.4 By Application
    • 5.4.1 Diagnostic Applications
    • 5.4.2 Research Applications
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 France
      • 5.5.2.2 Germany
      • 5.5.2.3 United Kingdom
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle-East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 Biomerieux SA
    • 6.1.4 Bio-Rad Laboratories Inc
    • 6.1.5 CareDx
    • 6.1.6 F. Hoffman-La Roche Limited
    • 6.1.7 Hologic
    • 6.1.8 Illumina
    • 6.1.9 Qiagen
    • 6.1.10 Thermo Fisher Scientific, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS